Vojdani A - Search Results

1

Regulatory T cells, a potent immunoregulatory target for CAM researchers: the ultimate antagonist (I).

Vojdani A, Erde J. Vojdani A, et al. Evid Based Complement Alternat Med. 2006 Mar;3(1):25-30. doi: 10.1093/ecam/nek022. Epub 2006 Feb 7. Evid Based Complement Alternat Med. 2006. PMID: 16550220 Free PMC article.

2

The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III.

Vojdani A, Lambert J, Kellermann G. Vojdani A, et al. Evid Based Complement Alternat Med. 2011;2011:548086. doi: 10.1093/ecam/nep064. Epub 2011 Jun 16. Evid Based Complement Alternat Med. 2011. PMID: 19622602 Free PMC article.

3

The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part II.

Vojdani A, Lambert J. Vojdani A, et al. Evid Based Complement Alternat Med. 2011;2011:984965. doi: 10.1093/ecam/nep063. Epub 2011 Jun 16. Evid Based Complement Alternat Med. 2011. PMID: 19622601 Free PMC article.

4

Novel Diagnosis of Lyme Disease: Potential for CAM Intervention.

Vojdani A, Hebroni F, Raphael Y, Erde J, Raxlen B. Vojdani A, et al. Evid Based Complement Alternat Med. 2009 Sep;6(3):283-95. doi: 10.1093/ecam/nem138. Epub 2007 Oct 15. Evid Based Complement Alternat Med. 2009. PMID: 18955246 Free PMC article.

5

Regulatory T cells, a potent immunoregulatory target for CAM researchers: modulating tumor immunity, autoimmunity and alloreactive immunity (III).

Vojdani A, Erde J. Vojdani A, et al. Evid Based Complement Alternat Med. 2006 Sep;3(3):309-16. doi: 10.1093/ecam/nel047. Epub 2006 Jul 5. Evid Based Complement Alternat Med. 2006. PMID: 16951715 Free PMC article.

6

Regulatory T Cells, a Potent Immunoregulatory Target for CAM Researchers: Modulating Allergic and Infectious Disease Pathology (II).

Vojdani A, Erde J. Vojdani A, et al. Evid Based Complement Alternat Med. 2006 Jun;3(2):209-15. doi: 10.1093/ecam/nel020. Epub 2006 Apr 19. Evid Based Complement Alternat Med. 2006. PMID: 16786050 Free PMC article.

7

The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part I.

Vojdani A, Lambert J. Vojdani A, et al. Evid Based Complement Alternat Med. 2011;2011:927294. doi: 10.1093/ecam/nep062. Epub 2011 Jun 16. Evid Based Complement Alternat Med. 2011. PMID: 19622600 Free PMC article.

8

Antibodies as predictors of complex autoimmune diseases.

Vojdani A. Vojdani A. Int J Immunopathol Pharmacol. 2008 Apr-Jun;21(2):267-78. doi: 10.1177/039463200802100203. Int J Immunopathol Pharmacol. 2008. PMID: 18547471 Review.

9

For the assessment of intestinal permeability, size matters.

Vojdani A. Vojdani A. Altern Ther Health Med. 2013 Jan-Feb;19(1):12-24. Altern Ther Health Med. 2013. PMID: 23341423 Review.

10

Antibodies to myelin basic protein, myelin oligodendrocytes peptides, alpha-beta-crystallin, lymphocyte activation and cytokine production in patients with multiple sclerosis.

Vojdani A, Vojdani E, Cooper E. Vojdani A, et al. Among authors: vojdani e. J Intern Med. 2003 Oct;254(4):363-74. doi: 10.1046/j.1365-2796.2003.01203.x. J Intern Med. 2003. PMID: 12974875

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results